Rational construction of genome-minimized Streptomyces host for the expression of secondary metabolite gene clusters

Streptomyces offer a wealth of naturally occurring compounds with diverse structures,many of which possess significant pharmaceutical values.However,new product exploration and increased yield of specific compounds in Streptomyces have been technically challenging due to their slow growth rate,complex culture conditions and intricate genetic backgrounds.In this study,we screened dozens of Streptomyces strains inhabiting in a plant rhizosphere for fast-growing candidates,and further employed CRISPR/Cas-based engineering techniques for stepwise refinement of a particular strain,Streptomyces sp.A-14 that harbors a 7.47 Mb genome.After strategic removal of nonessential genomic regions and most gene clusters,we reduced its genome size to 6.13 Mb,while preserving its growth rate to the greatest extent.We further demonstrated that cleaner metabolic background of this engineered strain was well suited for the expression and characterization of heterologous gene clusters,including the biosynthetic pathways of actinorhodin and polycyclic tetramate macrolactams.Moreover,this streamlined genome is anticipated to facilitate directing the metabolic flux towards the production of desired compounds and increasing their yields.